Prelims are in line with January’s positive year-end update and confirm a continuation of key themes established in H1, namely strong billings growth and cost discipline – together achieving FY16 adj. EBITDA of $3.7m. This is a complete turnaround from the heavy losses sustained in previous years and is testament to the business’s evolution. Encouragingly, traction has continued in FY17 and even accelerated in certain geographies, with domains under management up by c.40% by
25 Apr 2017
Prelims pressing ahead
Sign up to access
Get access to our full offering from over 30 providers
Get access to our full offering from over 30 providers
Prelims pressing ahead
- Published:
25 Apr 2017 -
Author:
Cavendish Research -
Pages:
6
Prelims are in line with January’s positive year-end update and confirm a continuation of key themes established in H1, namely strong billings growth and cost discipline – together achieving FY16 adj. EBITDA of $3.7m. This is a complete turnaround from the heavy losses sustained in previous years and is testament to the business’s evolution. Encouragingly, traction has continued in FY17 and even accelerated in certain geographies, with domains under management up by c.40% by